DNA Alkylating Therapy Induces Tumor Regression through an HMGB1-Mediated Activation of Innate Immunity
Jennifer L. Guerriero(Brigham and Women's Hospital), Wei‐Xing Zong(Stony Brook University)
Cited by 87
Related Papers
Necrotic death as a cell fate
|Genes & Development|2006|901
Akt and c-Myc Differentially Activate Cellular Metabolic Programs and Prime Cells to Bioenergetic Inhibition
|Journal of Biological Chemistry|2009|117
Glutamine synthetase limits β-catenin–mutated liver cancer growth by maintaining nitrogen homeostasis and suppressing mTORC1
|Journal of Clinical Investigation|2022|63